QUESTION: The markets in US and India have been able to offset the drag brought about by China this time around and it seems that the focus is still going to be US, going forward, being the destination for Temasek's capital. How long do you think you would have to rely on the US markets to maybe offset the drag from China and specifically on the Singapore market, I mean the public market also has its own issues, it is not doing too well. Any concerns about how that might impact Temasek's portfolio as well and how do you plan to navigate that?
PNG CHIN YEE: As Song Hwee has mentioned, we opened up offices in New York and London 10 years ago, precisely to diversify away exposure from Singapore and China, and we saw opportunities in those markets, so we have been actually building up our presence, our capabilities, and our exposure in those markets. But if you look at it, in some ways, we are still very underweight in those markets, so we expect the trend to continue for right now and so we would want to, as you rightly pointed out, continue to invest in both India as well as the US.
We do see opportunities across different spaces. For example, in the US, whereas you might think that valuations are quite high, particularly with the Magnificent 7, actually if you look beyond that and you look at the S&P Equal Weight, valuations still look reasonable in certain sectors. We see US as a very deep market with a lot of innovation and so that is a good place for our capital to be in.
Similarly in India, we have seen the stock markets scale new heights, but if you dig down and you peel the onion a little bit and you see – in the financial space, in the banking space, for example – valuations are still reasonable and we have historically had a very strong financial services portfolio in India, so we will continue to build on that, as well as look at healthcare and consumer. Last year, we made a large investment in the healthcare space with our ~S$3 billion investment in Manipal Hospitals. These are deep markets which afford us the compelling risk/rewards for the moment, and so we will continue to invest in those markets. We are also doing a lot in terms of active engagement with our Singapore portfolio companies which are an important part of our portfolio. Maybe, Song Hwee, you would like to talk a bit about that.
CHIA SONG HWEE: Yes, but before I do so, let me touch on China. As I mentioned earlier, we are investing in newer areas, focusing on the domestic market and continuing to reshape our portfolio to be more future proof, so to speak. We hope that with the reshaping of our portfolio plus the drop in the market value that has already occurred, that the downside will be more moderated, if there is any. But obviously, we are expecting in due course that the market will recover.
Specifically for our Singapore portfolio company, 40% of our portfolio value comes from our Temasek Portfolio Companies (TPCs). Over the years, many of them have gone through a transformation journey. DBS has gone through digitisation, giving it a very big push. CapitaLand has restructured their business into fund management as well as development and so on, and you can see the good results that they have brought about. And as far as Temasek is concerned, as Connie has mentioned, our job is to engage our portfolio companies so that they can produce better performance and build businesses that are sustainable into the future.
So, we do not actually differentiate whether or not it is a Singapore based or a non-Singapore based company. The engagement to create value, to enhance shareholders' value, is consistently applied.